Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Arginine Supplementation in Pre-Eclampsia
NCT00157521Phase 3Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Sep 2002
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of arginine in preeclampsia (3 arms), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoints: Nitric Oxide Production, L-arginine Transport Activity and 1 more. Started Sep 2002; status: completed.
02
Drugs
arginine
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT00157521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157521.